Tablets & Capsules

TC0315

Issue link: http://www.e-digitaleditions.com/i/477622

Contents of this Issue

Navigation

Page 23 of 53

22 March 2015 Tablets & Capsules Best Formulations Company manufactures and packages nutraceuticals and pharmaceuticals. Expertise includes formulating and manufacturing gelatin and vegetarian softgels, hard shell capsules, coated and uncoated tablets, as well as powders and teas. Additional services include blend- ing, granulation, and raw material sourcing. Company's 120,000-square- foot FDA-inspected facility holds Cali- fornia drug license, and GMP certifica- tions from NSF and NPA; organic, kosher, and halal products are also avail- able. In 2014, company added Bosch high-speed capsule filler, two softgel machines (13 lines total), two Fette tablet presses, and pouch packager; it also added GC-MS and ICP-MS instruments to its in-house lab. Best Formulations, City of Industry, CA. Tel. 626 912 9998 www.bestformulations.com Techceuticals Company offers tablet and capsule manufacturing training, consults on manufactur- ing processes, and sells used equipment. Classroom and hands-on training is offered at your site or at its facility; company stocks large inventory of pharma equipment. Website offers technical help, tips, and articles. Techceuticals, Cleveland, OH. Tel. 216 658 8038 www.techceuticals.com Xcelience Contract research organization of - fers suite of services, from pre-formula- tion through clinical distribution, including analytical and method devel- opment and validation, formulation development, and clinical supplies packaging. Company offers API-spar- ing strategies, including neat API-in- capsule service that reduces time to first-in-human studies by as much as 45 percent compared to traditional drug development programs. Xcelience, Tampa, FL. Tel. 813 286 0404 www.xcelience.com Metrics Contract Services Company offers full-service contract development and manufacturing services, includ- ing analytical and formulation development, and production of clinical trial materials for phases I to III. Expertise includes handling Schedule II through V controlled sub- stances and bioavailability enhancement. Facility for potent and cytotoxic substances includes Xcelodose micro-dosing system that shortens time to Phase I trials. Facility also features dedicated isolation system, with containment at about 30 nanograms per cubic meter of room air; air handling system brings in 100 percent outside air with HEPA-in/HEPA-out filtering. Company is part of Mayne Pharma, giving it global reach. Metrics Contract Services, Greenville, NC. Tel. 252 752 3800 www.metricsinc.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0315